Older white males with advanced bladder cancer more likely to commit suicide
the ONA take:
Older white males with advanced bladder cancer are the most likely to commit suicide among patients with genitourinary cancers, according to a recent study published in Cancer.
Zachary Klaassen, MD, of the Medical College of Georgia at Georgia Regents University and fellow researchers looked through the NCI’s SEER database from 1988 to 2010 and identified 1.2 million patients with cancer of the prostate, bladder, kidney, testes, and penis. They examined variables such as age, sex, race, as well as the aggressiveness of both the disease and treatment.
Their findings stressed suicide as a matter of public concern that requires physician awareness among men with genitourinary cancers. In particular, patients who were older, male and have more aggressive disease were found to be the most likely to commit suicide.
“The older, white, single male is already at higher risk in the general society for suicide,” Dr. Klaassen said. “Add on the fact that he has advanced bladder cancer and this is a high-risk patient. But this has taught me that we have to look for warning signs in all these patients.”
Older white males with advanced bladder cancer are the most likely to commit suicide among patients with genitourinary cancers.
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Compound in Teas, Peas, Soybeans May Increases Prostate Cancer Risk
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- A Case of Immunotherapy-Induced Myocarditis Concomitant to MG in Lung Cancer
- Online Learning Modules Improve Exercise Counseling, But Not Participation
- ASCO Issues Statement Addressing Alcohol and Cancer
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- Drug Combination Does Not Extend Glioblastoma Survival
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|